463 related articles for article (PubMed ID: 17174611)
21. Effect of change in an inhibitory neurotransmitter of the myenteric plexus on the pathogenetic mechanism of irritable bowel syndrome subgroups in rat models.
Xu JR; Luo JY; Shang L; Kong WM
Chin J Dig Dis; 2006; 7(2):89-96. PubMed ID: 16643336
[TBL] [Abstract][Full Text] [Related]
22. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
Ersryd A; Posserud I; Abrahamsson H; Simrén M
Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480
[TBL] [Abstract][Full Text] [Related]
23. Impact of depressive symptoms on visceral sensitivity among patients with different subtypes of irritable bowel syndrome.
de Medeiros MT; Carvalho AF; de Oliveira Lima JW; Dos Santos AA; de Oliveira RB; Nobre E Souza MA
J Nerv Ment Dis; 2008 Sep; 196(9):711-4. PubMed ID: 18791434
[TBL] [Abstract][Full Text] [Related]
24. Effects of chili on postprandial gastrointestinal symptoms in diarrhoea predominant irritable bowel syndrome: evidence for capsaicin-sensitive visceral nociception hypersensitivity.
Gonlachanvit S; Mahayosnond A; Kullavanijaya P
Neurogastroenterol Motil; 2009 Jan; 21(1):23-32. PubMed ID: 18647268
[TBL] [Abstract][Full Text] [Related]
25. Symptom severity but not psychopathology predicts visceral hypersensitivity in irritable bowel syndrome.
van der Veek PP; Van Rood YR; Masclee AA
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):321-8. PubMed ID: 18258487
[TBL] [Abstract][Full Text] [Related]
26. Symptom differences in moderate to severe IBS patients based on predominant bowel habit.
Schmulson M; Lee OY; Chang L; Naliboff B; Mayer EA
Am J Gastroenterol; 1999 Oct; 94(10):2929-35. PubMed ID: 10520847
[TBL] [Abstract][Full Text] [Related]
27. Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients.
Schmulson M; Chang L; Naliboff B; Lee OY; Mayer EA
Am J Gastroenterol; 2000 Jan; 95(1):152-6. PubMed ID: 10638575
[TBL] [Abstract][Full Text] [Related]
28. [Differences in the stress symptoms rating scale in Spanish between patients with irritable bowel syndrome (IBS) and healthy controls].
Huerta I; Bonder A; López L; Ocampo MA; Schmulson M
Rev Gastroenterol Mex; 2002; 67(3):161-5. PubMed ID: 12653052
[TBL] [Abstract][Full Text] [Related]
29. Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.
Leventer SM; Raudibaugh K; Frissora CL; Kassem N; Keogh JC; Phillips J; Mangel AW
Aliment Pharmacol Ther; 2008 Jan; 27(2):197-206. PubMed ID: 17973974
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
Rahimi R; Nikfar S; Abdollahi M
Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
[TBL] [Abstract][Full Text] [Related]
31. Bloating and distention in irritable bowel syndrome: the role of visceral sensation.
Agrawal A; Houghton LA; Lea R; Morris J; Reilly B; Whorwell PJ
Gastroenterology; 2008 Jun; 134(7):1882-9. PubMed ID: 18455167
[TBL] [Abstract][Full Text] [Related]
32. Abdominal symptoms and anorectal function in health and irritable bowel syndrome.
Ragnarsson G; Hallböök O; Bodemar G
Scand J Gastroenterol; 2001 Aug; 36(8):833-42. PubMed ID: 11495079
[TBL] [Abstract][Full Text] [Related]
33. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes.
Dunlop SP; Hebden J; Campbell E; Naesdal J; Olbe L; Perkins AC; Spiller RC
Am J Gastroenterol; 2006 Jun; 101(6):1288-94. PubMed ID: 16771951
[TBL] [Abstract][Full Text] [Related]
34. Role of colonic fermentation in the perception of colonic distention in irritable bowel syndrome and functional bloating.
Di Stefano M; Miceli E; Missanelli A; Mazzocchi S; Tana P; Corazza GR
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1242-7. PubMed ID: 16979386
[TBL] [Abstract][Full Text] [Related]
35. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome.
Simrén M; Abrahamsson H; Björnsson ES
Gut; 2001 Jan; 48(1):20-7. PubMed ID: 11115818
[TBL] [Abstract][Full Text] [Related]
36. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.
Atkinson W; Lockhart S; Whorwell PJ; Keevil B; Houghton LA
Gastroenterology; 2006 Jan; 130(1):34-43. PubMed ID: 16401466
[TBL] [Abstract][Full Text] [Related]
37. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.
Lee KJ; Kim YB; Kim JH; Kwon HC; Kim DK; Cho SW
J Gastroenterol Hepatol; 2008 Nov; 23(11):1689-94. PubMed ID: 19120860
[TBL] [Abstract][Full Text] [Related]
38. Do male sex hormones protect from irritable bowel syndrome?
Houghton LA; Jackson NA; Whorwell PJ; Morris J
Am J Gastroenterol; 2000 Sep; 95(9):2296-300. PubMed ID: 11007231
[TBL] [Abstract][Full Text] [Related]
39. Recto-colonic reflex is impaired in patients with irritable bowel syndrome.
van der Veek PP; Steenvoorden M; Steens J; van der Schaar PJ; Brussee J; Masclee AA
Neurogastroenterol Motil; 2007 Aug; 19(8):653-9. PubMed ID: 17640180
[TBL] [Abstract][Full Text] [Related]
40. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome.
Piche T; Saint-Paul MC; Dainese R; Marine-Barjoan E; Iannelli A; Montoya ML; Peyron JF; Czerucka D; Cherikh F; Filippi J; Tran A; Hébuterne X
Gut; 2008 Apr; 57(4):468-73. PubMed ID: 18194987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
